oxiracetam has been researched along with Apoplexy in 5 studies
oxiracetam: structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we investigated the therapeutic effects of combined bone marrow stromal cells (BMSCs) and oxiracetam treatments on acute cerebral ischemia/reperfusion (I/R) injury." | 7.91 | Combined bone marrow stromal cells and oxiracetam treatments ameliorates acute cerebral ischemia/reperfusion injury through TRPC6. ( Li, Z; Pan, Y; Sun, R; Wang, J, 2019) |
| "Oxiracetam may have a modest effect on preventing cognitive decline." | 5.69 | Efficacy and safety of oxiracetam in patients with vascular cognitive impairment: A multicenter, randomized, double-blinded, placebo-controlled, phase IV clinical trial. ( Bae, HJ; Cha, JK; Chang, DI; Cho, HJ; Cho, KH; Choi, JC; Chung, JW; Heo, JH; Heo, SH; Jung, KH; Kang, Y; Kim, C; Kim, DE; Kim, EG; Kim, HY; Kim, JG; Kim, YI; Kwon, JH; Lee, J; Lee, JH; Lee, KB; Lee, SJ; Lee, YB; Lee, YS; Lim, JS; Moon, WJ; Oh, KM; Oh, MS; Park, H; Park, HT; Park, JH; Park, JM; Park, JW; Park, KY; Park, MS; Park, TH; Rha, JH; Sung, SM; Yi, S, 2023) |
| "In this study, we use the middle cerebral artery occlusion/reperfusion (MCAO/R) model in rats and oxygen glucose deprivation/reoxygenation (OGD/R) model in fetal rat primary cortical neurons to investigate whether and how S-oxiracetam (S-ORC) protect brain injury from ischemic stroke." | 5.48 | S-oxiracetam ameliorates ischemic stroke induced neuronal apoptosis through up-regulating α7 nAChR and PI3K / Akt / GSK3β signal pathway in rats. ( Fan, W; Fang, W; Fu, Y; He, S; Huang, L; Li, X; Li, Y; Xie, Z, 2018) |
| " The clinical efficacy of nicergoline combined with oxiracetam in the treatment of vascular cognitive impairment after stroke was analyzed." | 5.34 | Clinical efficacy and safety of nicergoline combined with oxiracetam in the treatment of vascular cognitive impairment. ( Ma, Z; Qiao, P; Wang, B; Zhong, L, 2020) |
| " In this study, we investigated the therapeutic effects of combined bone marrow stromal cells (BMSCs) and oxiracetam treatments on acute cerebral ischemia/reperfusion (I/R) injury." | 3.91 | Combined bone marrow stromal cells and oxiracetam treatments ameliorates acute cerebral ischemia/reperfusion injury through TRPC6. ( Li, Z; Pan, Y; Sun, R; Wang, J, 2019) |
| "In this study, we use the middle cerebral artery occlusion/reperfusion (MCAO/R) model in rats and oxygen glucose deprivation/reoxygenation (OGD/R) model in fetal rat primary cortical neurons to investigate whether and how S-oxiracetam (S-ORC) protect brain injury from ischemic stroke." | 1.48 | S-oxiracetam ameliorates ischemic stroke induced neuronal apoptosis through up-regulating α7 nAChR and PI3K / Akt / GSK3β signal pathway in rats. ( Fan, W; Fang, W; Fu, Y; He, S; Huang, L; Li, X; Li, Y; Xie, Z, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lim, JS | 1 |
| Lee, J | 2 |
| Kang, Y | 1 |
| Park, HT | 1 |
| Kim, DE | 1 |
| Cha, JK | 1 |
| Park, TH | 1 |
| Heo, JH | 1 |
| Lee, KB | 1 |
| Park, JM | 1 |
| Oh, MS | 1 |
| Kim, EG | 1 |
| Chang, DI | 1 |
| Heo, SH | 1 |
| Park, MS | 1 |
| Park, H | 1 |
| Yi, S | 1 |
| Lee, YB | 1 |
| Park, KY | 1 |
| Lee, SJ | 1 |
| Kim, JG | 1 |
| Cho, KH | 1 |
| Rha, JH | 1 |
| Kim, YI | 1 |
| Lee, JH | 1 |
| Choi, JC | 1 |
| Oh, KM | 1 |
| Kwon, JH | 1 |
| Kim, C | 1 |
| Park, JH | 1 |
| Jung, KH | 1 |
| Sung, SM | 1 |
| Chung, JW | 1 |
| Lee, YS | 1 |
| Kim, HY | 1 |
| Cho, HJ | 1 |
| Park, JW | 1 |
| Moon, WJ | 1 |
| Bae, HJ | 1 |
| Wang, B | 1 |
| Zhong, L | 1 |
| Qiao, P | 1 |
| Ma, Z | 1 |
| Huang, L | 2 |
| Shang, E | 1 |
| Fan, W | 2 |
| Li, X | 2 |
| Li, B | 1 |
| He, S | 2 |
| Fu, Y | 2 |
| Zhang, Y | 1 |
| Li, Y | 2 |
| Fang, W | 2 |
| Xie, Z | 1 |
| Wang, J | 1 |
| Sun, R | 1 |
| Li, Z | 1 |
| Pan, Y | 1 |
2 trials available for oxiracetam and Apoplexy
| Article | Year |
|---|---|
Efficacy and safety of oxiracetam in patients with vascular cognitive impairment: A multicenter, randomized, double-blinded, placebo-controlled, phase IV clinical trial.
Topics: Cognitive Dysfunction; Double-Blind Method; Humans; Pyrrolidines; Quality of Life; Stroke; Treatment | 2023 |
Clinical efficacy and safety of nicergoline combined with oxiracetam in the treatment of vascular cognitive impairment.
Topics: Adult; Aged; Aged, 80 and over; Cognitive Dysfunction; Drug Therapy, Combination; Female; Humans; Ma | 2020 |
3 other studies available for oxiracetam and Apoplexy
| Article | Year |
|---|---|
S-oxiracetam protect against ischemic stroke via alleviating blood brain barrier dysfunction in rats.
Topics: Animals; Atenolol; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cla | 2017 |
S-oxiracetam ameliorates ischemic stroke induced neuronal apoptosis through up-regulating α7 nAChR and PI3K / Akt / GSK3β signal pathway in rats.
Topics: Animals; Apoptosis; Brain Ischemia; Cell Survival; Infarction, Middle Cerebral Artery; Male; Neurons | 2018 |
Combined bone marrow stromal cells and oxiracetam treatments ameliorates acute cerebral ischemia/reperfusion injury through TRPC6.
Topics: Animals; Bone Marrow Transplantation; Brain Ischemia; Calpain; Cerebral Cortex; Cyclic AMP Response | 2019 |